Capital Investment Advisors »

Biomarin Pharmaceutical shares owned by Capital Investment Advisors

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Capital Investment Advisors from 13F filings

Historical chart of Capital Investment Advisors investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Capital Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Capital Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $11k 11k 0.99
2023-12-31 $11k 11k 1.03

More positions owned by Capital Investment Advisors

Ishares Tr Core Div Grwth (DGRO)
Ishares Tr Msci Intl Qualty (IQLT)
Proshares Tr Russ 2000 Divd (SMDV)
First Tr Exchange-traded No Amer Energy (EMLP)
Home Depot (HD)
Vaneck Etf Trust Fallen Angel Hg (ANGL)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation (MSFT)
Spdr Ser Tr S&p Divid Etf (SDY)
Apple (AAPL)
Johnson & Johnson (JNJ)
Select Sector Spdr Tr Technology (XLK)
Ishares Tr Ibds Dec28 Etf (IBDT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Ibonds 25 Trm Ts (IBTF)

View all positions for Capital Investment Advisors

Top funds holding Biomarin Pharmaceutical

MacKay Shields
Lazard Asset Management
Wellesley Investment Advisors
Victory Capital Management
iA Global Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Shenkman Capital Management
Bank of America Corporation
Jpmorgan Chase & Co
Wellington Management Company
Amundi
New York State Common Retirement Fund
Bnp Paribas Investment Partners
SSI Investment Management
La Banque Postale Asset Management SA

View all funds holding Biomarin Pharmaceutical